Matthias W. Beckmann

German researcher

Born 1960-01-01

Matthias W. Beckmann is …
instance of (P31):
humanQ5

External links are
P8168FactGrid item IDQ885393
P227GND ID112832776
P10299Leopoldina member ID (new)matthias-w-beckmann
P214VIAF ID673623
P7859WorldCat Identities ID (superseded)lccn-n2015016908

P166award receivedCross of the Order of Merit of the Federal Republic of GermanyQ10905380
P27country of citizenshipGermanyQ183
P734family nameBeckmannQ813731
BeckmannQ813731
BeckmannQ813731
P735given nameMatthiasQ4927273
MatthiasQ4927273
P1412languages spoken, written or signedGermanQ188
P463member ofGerman Academy of Sciences LeopoldinaQ543804
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q3601638611q13 is a susceptibility locus for hormone receptor positive breast cancer
Q3031757013th st. Gallen international breast cancer conference 2013: primary therapy of early breast cancer evidence, controversies, consensus - opinion of a german team of experts (zurich 2013).
Q3031597014th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts
Q3420916718-Year-Old Woman with an Embryonal Rhabdomyosarcoma of the Uterus in Statu Nascendi
Q3587156719p13.1 is a triple-negative-specific breast cancer susceptibility locus
Q338488952q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy
Q360214067q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium
Q371698739q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium
Q26768670A Review of Integrative Medicine in Gynaecological Oncology
Q40486932A Standard Mammography Unit - Standard 3D Ultrasound Probe Fusion Prototype: First Results
Q35755874A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer
Q35957063A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density
Q33747778A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.
Q29417084A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.
Q53650107A hybrid method towards automated nipple detection in 3D breast ultrasound images.
Q37619303A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium
Q35089479A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population
Q36435849A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.
Q24626194A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer
Q37575167A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study
Q33947899ABCA transporter gene expression and poor outcome in epithelial ovarian cancer
Q37227494ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas
Q62583469Abstract 5488: Utilizing a pathway based analysis of genome wide association data to identify biomarkers of toxicity in breast cancer patients
Q46169815Abstract 73: Selective Isolation And Characterization Of Different Cell Types From Mammary Gland And Carcinoma Tissue For Subsequent Analysis Of Cell-cell Interactions.
Q38371558Accelerated Partial Breast Irradiation With Interstitial Implants: Risk Factors Associated With Increased Local Recurrence
Q40497331Accelerated partial breast irradiation with external beam radiotherapy : First results of the German phase 2 trial
Q47347187Accuracy of radiological tumour size assessment and the risk for re-excision in a cohort of primary breast cancer patients
Q58695244Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria
Q38406780Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study
Q52647897Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.
Q39432829Akt and p53 are potential mediators of reduced mammary tumor growth by cloroquine and the mTOR inhibitor RAD001.
Q34371653An EMR based cancer diary - utilisation and initial usability evaluation of a new cancer data visualization tool
Q36073563An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression
Q61853700An interleukin-6 gene promoter polymorphism influences the biological phenotype of ovarian cancer
Q42371458Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci
Q35874160Analysis and classification of oncology activities on the way to workflow based single source documentation in clinical information systems
Q64101095Analysis of GDF15 and IGFBP7 in Hyperemesis Gravidarum Support Causality
Q36831854Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome
Q38667762Anti-Müllerian hormone (AMH) levels in premenopausal breast cancer patients treated with taxane-based adjuvant chemotherapy - A translational research project of the SUCCESS A study
Q47102240Antioxidant effect of aqueous extract of four plants with therapeutic potential on gynecological diseases; Semen persicae, Leonurus cardiaca, Hedyotis diffusa, and Curcuma zedoaria
Q50799567Apolipoprotein E synthesis by cultured human ovarian granulosa cells: regulation by human chorionic gonadotropin and cholesterol
Q62583468Arbeitsgruppe Integrative Medizin (AG IMed) der AGO e.V.. Begriffsdefinition, Gründung, Ziele und Perspektiven der AG Integrative Medizin
Q34138371Are Certified Breast Centers Cost-Effective?
Q35142156Aspects of molecular diagnostics and therapy in obstetrics and gynecology
Q34613673Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study
Q30276986Assessing the genetic architecture of epithelial ovarian cancer histological subtypes
Q50958797Assessment of FSHR variants and antimüllerian hormone in infertility patients with a reduced ovarian response to gonadotropin stimulation.
Q37383194Assessment of University Gynaecology Clinics Based on Quality Reports
Q46687084Assessment of breast cancer tumor size depends on method, histopathology and tumor size itself*.
Q47399153Assessment of breast cancer tumour size using six different methods
Q46186737Assessment of pituitary and steroid hormones and members of the TGF-beta superfamily for ovarian function in patients with congenital uterus and vaginal aplasia (MRKH syndrome).
Q35218520Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy
Q37684409Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer
Q45979098Association analysis identifies 65 new breast cancer risk loci.
Q35006860Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen
Q33828680Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival
Q37292963Association of ESR1 gene tagging SNPs with breast cancer risk
Q37268494Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry
Q53650262Association of mammographic density with hormone receptors in invasive breast cancers: results from a case-only study.
Q44287591Association of mammographic density with the proliferation marker Ki-67 in a cohort of patients with invasive breast cancer
Q41706112Association of molecular subtypes with breast cancer risk factors: a case-only analysis
Q43271915Association of thyroid-stimulating hormone with insulin resistance and androgen parameters in women with PCOS.
Q39423088Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study
Q35022847Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies
Q35532898Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium
Q57056093Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis
Q33812789Attention, cognitive control and motivation in ADHD: Linking event-related brain potentials and DNA methylation patterns in boys at early school age.
Q46143272Automatic texture-based analysis in ultrasound imaging of ovarian masses
Q57990746BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients
Q36295142Biomarkers in Breast Cancer - An Update
Q43945969Blood group A: an overseen risk factor for early-onset ovarian hyperstimulation syndrome?
Q51553410Body composition and bone mineral density in male-to-female transsexuals during cross-sex hormone therapy using gonadotrophin-releasing hormone agonist.
Q42165395Body mass index and ovarian function are associated with endocrine and metabolic abnormalities in women with hyperandrogenic syndrome
Q70536430Breaks in DNA accompany estrogen-receptor-mediated cytotoxicity from 16 alpha[125I]iodo-17 beta-estradiol
Q37660589Breast Cancer Risk - From Genetics to Molecular Understanding of Pathogenesis
Q34201805Breast Cancer Risk - Genes, Environment and Clinics
Q43122429Breast cancer risk assessment in a mammography screening program and participation in the IBIS-II chemoprevention trial
Q35940158Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.
Q44973328Breast cancer: assessment of individual risk and possibilities for prevention
Q39978884Breast volumetry using a three-dimensional surface assessment technique
Q52849107CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients.
Q53407302CD95 ligand expression as a criterion of malignant transformation in breast cancer.
Q73395786CD95 ligand expression as a mechanism of immune escape in breast cancer
Q56975238CD95 ligand expression in dedifferentiated breast cancer
Q36620625CDKN2A gene inactivation in epithelial sporadic ovarian cancer
Q36449203CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer
Q36419325CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer
Q34793437CYP2B6*6 is associated with increased breast cancer risk
Q37524058CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations
Q61446902Can a University Reproductive Medicine Centre Be Financed Under the Pre-Existing General Conditions in Germany?
Q28385765Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk
Q43639604Capecitabine plus paclitaxel versus epirubicin plus paclitaxel as first-line treatment for metastatic breast cancer: efficacy and safety results of a randomized, phase III trial by the AGO Breast Cancer Study Group
Q33481987Certification of breast centres in Germany: proof of concept for a prototypical example of quality assurance in multidisciplinary cancer care
Q36286192Cervical Cancer Screening: Defining the Need for Research
Q53172588Changes in satisfaction in patients with gynaecological and breast malignancies: an analysis with the Socio-Economic Satisfaction and Quality of Life questionnaire.
Q36245595Characterizing mammographic images by using generic texture features
Q51532003Chelidonium majus and its effects on uterine contractility in a perfusion model.
Q57098750Children of Prenatally Depressed Mothers: Externalizing and Internalizing Symptoms are Accompanied by Reductions in Specific Social-Emotional Competencies
Q73020768Chronic pelvic pain syndrome (CPPS) and chronic vulvar pain syndrome (CVPS): evaluation of psychosomatic aspects
Q47657648Chylous ascites after lymphadenectomy for gynecological malignancies
Q34221705Circulating miR-148b and miR-133a as biomarkers for breast cancer detection
Q21134914Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection
Q33958981Circulating tumor cells predict survival in early average-to-high risk breast cancer patients
Q35782435Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer
Q33991395Clinical aspects of Mayer-Rokitansky-Kuester-Hauser syndrome: recommendations for clinical diagnosis and staging
Q36798908Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer
Q45746480Clinical validation of genetic variants associated with in vitro chemotherapy-related lymphoblastoid cell toxicity
Q35668946Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
Q34126314Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer
Q35891162Common breast cancer susceptibility loci are associated with triple-negative breast cancer
Q36600605Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk
Q35794653Common germline polymorphisms associated with breast cancer-specific survival
Q34379032Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium
Q29417145Common variants at 19p13 are associated with susceptibility to ovarian cancer
Q36255665Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer
Q31082788Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Q37681445Comparison of Obstetric Efficacy and Safety of the Kiwi OmniCup with Conventional Vacuum Extraction
Q35054469Comparison of Sonography versus Digital Breast Tomosynthesis to Locate Intramammary Marker Clips
Q53318719Comparison of Whole Ovary Cryotreatments for Fertility Preservation.
Q51035304Comparison of different diagnostic procedures for the staging of malformations associated with Mayer-Rokitansky-Küster-Hauser syndrome.
Q51281139Comparison of prevalence of hypoactive sexual desire disorder (HSDD) in women after five different hysterectomy procedures.
Q34428536Comparison of reoperation rates, perioperative outcomes in women with endometrial cancer when the standard of care shifts from open surgery to laparoscopy
Q62583610Comparison of total laparoscopic hysterectomy (TLH) and laparoscopy-assisted supracervical hysterectomy (LASH) in women with uterine leiomyoma
Q50648173Comparison of two freezing protocols in an open freezing system for cryopreservation of rat ovarian tissue.
Q72167239Comparisons of radioiodoestradiol blood-tissue exchange after intravenous or intraarterial injection
Q62583467Competitive analysis of pregnancy associated HLA-proteins in trophoblast and breast cancer tissue
Q36026731Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer
Q39256294Comprehensive visualization of paresthesia in breast cancer survivors
Q40069574Computer-assisted diagnosis in colposcopy: results of a preliminary experiment?
Q31107007Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patients
Q34181322Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer
Q26748714Considerations on the Improved Integration of Medical Guidelines into Routine Clinical Practice – a Review and Concept Proposal
Q34342248Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk
Q57278898Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Q46494349Correlates of the desire for improved cosmetic results after breast-conserving therapy and mastectomy in breast cancer patients
Q37855560Correlation of high-risk human papilloma viruses but not of herpes viruses or Chlamydia trachomatis with endometriosis lesions
Q37452184Correlation of histological and macroscopic findings in peritoneal endometriosis
Q34714884Correlations between anti-müllerian hormone, inhibin B, and activin A in follicular fluid in IVF/ICSI patients for assessing the maturation and developmental potential of oocytes.
Q34278775Cost-Benefit Analysis of Endocrine Therapy in the Adjuvant Setting for Postmenopausal Patients with Hormone Receptor-Positive Breast Cancer, Based on Survival Data and Future Prices for Generic Drugs in the Context of the German Health Care System
Q43100791Cost-effectiveness analysis of anastrozole versus tamoxifen in adjuvant therapy for early-stage breast cancer - a health-economic analysis based on the 100-month analysis of the ATAC trial and the German health system
Q47435062Cost-effectiveness of risk-reducing surgeries in preventing hereditary breast and ovarian cancer
Q34210292Cryopreservation of Ovarian Tissue: Detailed Description of Methods for Transport, Freezing and Thawing
Q37681448Culture of Individually Required Number of 2-Pronuclei-Stage Oocytes - Patient Participation in Decision-Making is in Accordance with the Aim of Avoiding Surplus Embryo Freezing
Q33626108DGGG Guidelines Programme: Status Quo - Quo Vadis!
Q36540420DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer
Q33209076DNA sequence variations of the entire anti-Mullerian hormone (AMH) gene promoter and AMH protein expression in patients with the Mayer-Rokitanski-Kuster-Hauser syndrome
Q34042835Defining CD95 as a tumor suppressor gene
Q48635565Delivery mode and the course of pre- and postpartum depression.
Q53400920Desire to Have Children Among Transgender People in Germany: A Cross-Sectional Multi-Center Study.
Q36069885Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial
Q73133671Detection of sequential genetic alterations relevant for breast cancer development
Q67516764Detection of the HER-2/neu proto-oncogene protein p185erbB2 by a novel monoclonal antibody (MAB-145ww) in breast cancer membranes from oestrogen and progesterone receptor assays
Q50186421Detyrosinated tubulin is decreased in fetal vessels of preeclampsia placentas.
Q35624654Development and Validation of a Standardized Questionnaire and Standardized Diary for Use in Integrative Medicine Consultations in Gynecologic Oncology
Q42483480Dexamethasone stimulates the expression of leptin and 11β-HSD2 in primary human placental trophoblastic cells
Q47952423Did you drink alcohol during pregnancy? Inaccuracy and discontinuity of women's self-reports: On the way to establish meconium ethyl glucuronide (EtG) as a biomarker for alcohol consumption during pregnancy
Q56679615Die Extrauteringravidität
Q54447695Differences in gene expression dependent on sampling site in placental tissue of fetuses with intrauterine growth restriction.
Q46310619Differences in muscarinic-receptor agonist-, oxytocin-, and prostaglandin-induced uterine contractions
Q50898218Differential effects of low birthweight and intrauterine growth restriction on umbilical cord blood insulin-like growth factor concentrations.
Q50868171Digit ratio (2D:4D) and behavioral symptoms in primary-school aged boys.
Q41506407Documentation Time and Effort and Associated Resources for Patients with Primary Breast Cancer from Diagnosis to End of Follow-Up - Results of a Multicentre Validation
Q48607117Does stimulation with human gonadotropins and gonadotropin-releasing hormone agonist enhance and accelerate the developmental capacity of oocytes in human ovarian tissue xenografted into severe combined immunodeficient mice?
Q47182019Dose adjustment of cisplatin, etoposide, and ifosfamide according to kidney function: a retrospective analysis and implications for medication safety
Q51200174Double-balloon catheter and sequential oral misoprostol versus oral misoprostol alone for induction of labour at term: a retrospective cohort study.
Q40465468Double-balloon catheter and sequential vaginal prostaglandin E2 versus vaginal prostaglandin E2 alone for induction of labor after previous cesarean section.
Q48672490Ductal carcinoma in situ -- do we really need a new nomenclature?
Q39445654Dynamic contrast-enhanced micro-CT on mice with mammary carcinoma for the assessment of antiangiogenic therapy response
Q36685211ERBB2 gene amplification detected by fluorescent differential polymerase chain reaction in paraffin‐embedded breast carcinoma tissues
Q39936321Early aberrant insulin-like growth factor signaling in the progression to endometrial carcinoma is augmented by tamoxifen
Q41375213Early cancer detection programmes for women at high risk for breast and ovarian cancer: a proposal of practical guidelines
Q38203252Economic constraints - the growing challenge for Western breast cancer centers
Q47104970Effect of Premature Rupture of Membranes on Induction of Labor: A Historical Cohort Study
Q46726174Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230.
Q51512980Effects of interactions between progesterone and prostaglandin on uterine contractility in a perfused swine uterus model.
Q43003217Effects of intramuscular testosterone undecanoate on body composition and bone mineral density in female-to-male transsexuals
Q47273243Effects of prenatal alcohol consumption on cognitive development and ADHD-related behaviour in primary-school age: a multilevel study based on meconium ethyl glucuronide
Q40273075Effects of the antiestrogens tamoxifen and raloxifene on the estrogen receptor transactivation machinery.
Q45982068Effects of transdermal testosterone or oral dydrogesterone on hypoactive sexual desire disorder in transsexual women: results of a pilot study.
Q58748170Effects of whole-body electromyostimulation combined with individualized nutritional support on body composition in patients with advanced cancer: a controlled pilot trial
Q34397557Efficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors: a multicenter phase 2 trial (AGO-GYN5).
Q41097198Efficient lysis of CD44v7/8-presenting target cells by genetically engineered cytotoxic T-lymphocytes--a model for immunogene therapy of cervical cancer
Q22250928Einfluss des mütterlichen Alkoholkonsums während der Schwangerschaft auf die Entwicklung von ADHS beim Kind
Q52681182Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study.
Q35794508Endogenous retroviral syncytin: compilation of experimental research on syncytin and its possible role in normal and disturbed human placentogenesis
Q35815412Endometriosis as a risk factor for ovarian or endometrial cancer - results of a hospital-based case-control study
Q37867025Endothelial Chlamydia pneumoniae infection promotes oxidation of LDL.
Q24633316Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer
Q36487146Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk
Q57961643Erratum to “Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients—Design and baseline data ‘LIBERATE’ trial” [The Breast 16S2 (2007) S182–S189]
Q42649791Erratum to: The integrative epigenomic-transcriptomic landscape of ER positive breast cancer
Q57319395Erratum: Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer
Q43179803Erratum: Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015).
Q34243929Establishment of the Certification System "Gynaecological Dysplasia" in Germany
Q28239860Estrogen and progesterone receptors: from molecular structures to clinical targets
Q33932856Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium
Q36617728European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables. Breast Cancer Somatic Genetics Consortium
Q36966218Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study
Q37389684Evaluation of Newly Adapted Clip Marker System in Ultrasound-Guided Core Needle Biopsy for Suspicion of Breast Cancer
Q34764981Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study
Q51809365Evaluation of high-sensitivity C-reactive protein in comparison with C-reactive protein as biochemical serum markers in women with endometriosis.
Q43697261Evaluation of mathematical models for breast cancer risk assessment in routine clinical use.
Q37719099Evaluation of two different analytical methods for circulating tumor cell detection in peripheral blood of patients with primary breast cancer
Q35653910Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk
Q34687073Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study
Q36720821Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors
Q35064451Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation
Q37342144Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation
Q42237987Ex vivo expansion of hematopoietic stem- and progenitor cells from cord blood in coculture with mesenchymal stroma cells from amnion, chorion, Wharton's jelly, amniotic fluid, cord blood, and bone marrow
Q71874733Expression analyses of epidermal growth factor receptor and HER-2/neu: no advantage of prediction of recurrence or survival in breast cancer patients
Q37631322Expression of neuroendocrine markers in different molecular subtypes of breast carcinoma
Q54455169Expression of the human endogenous retroviruse-W envelope gene syncytin in endometriosis lesions.
Q51409088Extracorporeal perfusion of the swine uterus: effect of human seminal plasma.
Q37594336FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium
Q30313653Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study
Q45006117Factors influencing breast changes after pregnancy
Q64935138Fat necrosis after conserving surgery and interstitial brachytherapy and/or external-beam irradiation in women with breast cancer.
Q40365623Feasibility and safety of total laparoscopic hysterectomy (TLH) using the Hohl instrument in nonobese and obese women
Q31150676FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients
Q51775578Female genital malformations and their associated abnormalities.
Q36539587Femoral Placement of Totally Implantable Venous Access Ports in Patients with Bilateral Breast Cancer
Q26771340Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled?
Q49340655Fertility protection: complications of surgery and results of removal and transplantation of ovarian tissue.
Q36841308Fetal Rhesus D genotyping on amniocytes in alloimmunised pregnancies using fluorescence duplex polymerase chain reaction
Q46500853Fetal weight estimation in extreme macrosomia (≥ 4,500 g): comparison of 10 formulas
Q49796329Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients.
Q50748345Financial viability of perinatal centers in the longer term, taking legislative requirements into account. An examination of the cost-revenue structure of a Level I perinatal center.
Q44318881Financing of certified centers: a willingness-to-pay analysis
Q37236216Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs).
Q36111237Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus
Q35524465Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.
Q35063160Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk
Q39844032Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer
Q36248936Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk
Q34903062Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.
Q37367871Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.
Q37002930Five endometrial cancer risk loci identified through genome-wide association analysis
Q34979715Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium
Q71722021Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer
Q36295117Full Field Digital Mammography (FFDM) versus CMOS Technology versus Tomosynthesis (DBT) - Which System Increases the Quality of Intraoperative Imaging?
Q37395450Full Field Digital Mammography (FFDM) versus CMOS Technology, Specimen Radiography System (SRS) and Tomosynthesis (DBT) - Which System Can Optimise Surgical Therapy?
Q51771739Fulvestrant: a further treatment option for patients with metastatic uterine cancer?
Q50053485Fumarate hydratase (FH) deficiency in uterine leiomyomas: recognition by histological features versus blind immunoscreening.
Q36124728Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus
Q36742577Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers
Q36956156GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer
Q55037331Galactography with Tomosynthesis Technique (Galactomosynthesis) - Renaissance of a Method?
Q73886723Gene amplification and expression of the steroid receptor coactivator SRC3 (AIB1) in sporadic breast and endometrial carcinomas
Q35793260Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation
Q48361014Gene panel sequencing in familial breast/ovarian cancer patients identifies multiple novel mutations also in genes others than BRCA1/2.
Q40137431Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium
Q41040904Genetic Breast Cancer Susceptibility Variants and Prognosis in the Prospectively Randomized SUCCESS A Study
Q37389405Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer
Q115209620Genetic analyses of gynecological disease identify genetic relationships between uterine fibroids and endometrial cancer, and a novel endometrial cancer genetic risk region at the WNT4 1p36.12 locus
Q37739048Genetic modifiers of CHEK2*1100delC-associated breast cancer risk
Q54940815Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses.
Q35925620Genetic predisposition to ductal carcinoma in situ of the breast
Q35151684Genetic predisposition to in situ and invasive lobular carcinoma of the breast
Q45968079Genetic risk factors for ovarian cancer and their role for endometriosis risk.
Q46721561Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto study
Q37679549Genetic variants in the genes of the stress hormone signalling pathway and depressive symptoms during and after pregnancy
Q48657862Genetic variants in the tryptophan hydroxylase 2 gene (TPH2) and depression during and after pregnancy.
Q35179897Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study
Q34378972Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade
Q30000080Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent
Q36218993Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium
Q36842233Genome-wide association analysis identifies three new breast cancer susceptibility loci
Q35996692Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
Q63681757Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer
Q24622610Genome-wide association studies identify four ER negative-specific breast cancer risk loci
Q29417100Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer
Q29417135Genome-wide association study identifies a common variant associated with risk of endometrial cancer
Q36024614Genome-wide association study identifies a possible susceptibility locus for endometrial cancer
Q33778612Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.
Q59566871Genomic analyses for age at menarche identify 389 independent signals and indicate BMI-independent effects of puberty timing on cancer susceptibility
Q38823212Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk
Q36916243Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer
Q30315508Gestational and Non-gestational Trophoblastic Disease. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No. 032/049, December 2015).
Q36539030Gonadal damage and options for fertility preservation in female and male cancer survivors
Q40090312Grating-based darkfield imaging of human breast tissue
Q41501180Growth inhibition of xenotransplanted human carcinomas by a monoclonal antibody directed against the epidermal growth factor receptor
Q38672994Gynecologic oncologists' attitudes and practices relating to integrative medicine: results of a nationwide AGO survey
Q28237833HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast Cancer
Q46188099HER2 and TOP2A amplification in a hospital-based cohort of breast cancer patients: associations with patient and tumor characteristics
Q38002315HIV-associated hypertrophic herpes simplex genitalis with concomitant early invasive squamous cell carcinoma mimicking advanced genital cancer: case report and literature review
Q46475402HOXA10 and HOXA13 sequence variations in human female genital malformations including congenital absence of the uterus and vagina
Q42191135HPV16-L1-specific antibody response is associated with clinical remission of high-risk HPV-positive early dysplastic lesions.
Q26996601Health Services Research and Health Economy - Quality Care Training in Gynaecology, with Focus On Gynaecological Oncology
Q37677719Health economics in breast cancer
Q48086218Health utilities in gynecological oncology and mastology in Germany
Q36276540Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization
Q36311502Hereditary breast and ovarian cancer: review and future perspectives
Q46580962High dose estrogen treatment increases bone mineral density in male-to-female transsexuals receiving gonadotropin-releasing hormone agonist in the absence of testosterone
Q35878239High incidence of recurrent copy number variants in patients with isolated and syndromic Müllerian aplasia
Q54566127Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - results of the eLEcTRA trial.
Q34010295Higher incidence of linked malformations in siblings of Mayer-Rokitansky-Küster-Hauser-syndrome patients
Q40060927History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium
Q46310632Hormonal and histologic findings in human cryopreserved ovarian autografts
Q35815464Hormone Therapy and its Effect on the Prognosis in Breast Cancer Patients
Q73843914Hormone replacement therapy after treatment of breast cancer: effects on postmenopausal symptoms, bone mineral density and recurrence rates
Q43694432Hormone replacement therapy and prognosis in ovarian cancer patients
Q34360924Hormones and hormone antagonists: mechanisms of action in carcinogenesis of endometrial and breast cancer
Q68037064Human ovarian granulosa cell culture: determination of blood cell contamination and evaluation of possible culture purification steps
Q47844735Hyperandrogenemia and high prolactin in congenital utero-vaginal aplasia patients
Q47110757Hypermethylation and loss of retinoic acid receptor responder 1 expression in human choriocarcinoma
Q33606770Hypohidrotic Ectodermal Dysplasia: Breastfeeding Complications Due to Impaired Breast Development
Q24595917Hysterectomy-a comparison of approaches
Q62583606Hysterektomie - was ist zeitgemäß?
Q38479085INT-2 gene amplification in differentiated human thyroid cancer.
Q35102646Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk
Q37006170Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.
Q30252854Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
Q36859142Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
Q34038964Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions
Q57170142Identification of nine new susceptibility loci for endometrial cancer
Q36014067Identification of novel genetic markers of breast cancer survival
Q35541663Identification of six new susceptibility loci for invasive epithelial ovarian cancer
Q46103372Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
Q71865988Immunohistochemical detection of epidermal growth factor receptor (EGF-R) in paraffin sections of breast carcinoma tissue: correlation and clinical significance
Q37382860Impact of Patient and Procedure Mix on Finances of Perinatal Centres - Theoretical Models for Economic Strategies in Perinatal Centres
Q50866974Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry.
Q38606464Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry
Q114184688Incorporating progesterone receptor expression into the PREDICT breast prognostic model
Q47212830Increased accuracy of fetal weight estimation with a gender-specific weight formula
Q64119524Induction of Labour in Growth Restricted and Small for Gestational Age Foetuses - A Historical Cohort Study
Q35428047Induction of Labour: Change of Method and its Effects
Q34764971Influence of Patient and Hospital Characteristics on the Performance of Direct Reconstruction after Mastectomy
Q48280760Influence of body mass index on induction of labor: A historical cohort study
Q47318223Influence of mammographic density on the diagnostic accuracy of tumor size assessment and association with breast cancer tumor characteristics
Q50089754Influence of patient and tumor characteristics on early therapy persistence with letrozole in postmenopausal women with early breast cancer: results of the prospective Evaluate-TM study with 3941 patients.
Q52572827Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: Results of the prospective EvAluate-TM study.
Q34996647Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer
Q37684424Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration
Q35104068Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer
Q36015063Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
Q35133135Inhibition of adhesion, proliferation, and invasion of primary endometriosis and endometrial stromal and ovarian carcinoma cells by a nonhyaluronan adhesion barrier gel.
Q37382839Innovations in Cervical and Endometrial Cancer
Q35687548Insights into the molecular biology of the estrogen receptor define novel therapeutic targets for breast cancer
Q58592781Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) - Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors o
Q58124814Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Brea
Q39390636Interest in Integrative Medicine Among Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study
Q64991267Intra- and Postoperative Blood Flow Monitoring in a Sheep Model of Uterus Transplantation.
Q35695189Intracellular actions of steroid hormones and their therapeutic value, including the potential of radiohalosteroids against ovarian cancer
Q38674400Intrauterine Growth Restriction (IUGR) Induces Signs of Subclinical Atherosclerosis in 6-Year-Old Infants Despite Absence Of Excessive Growth
Q52582782Introducing a novel highly prognostic grading scheme based on tumour budding and cell nest size for squamous cell carcinoma of the uterine cervix.
Q33990120Introduction of Inhaled Nitrous Oxide and Oxygen for Pain Management during Labour - Evaluation of Patients' and Midwives' Satisfaction
Q35576242Invasive Breast Cancer: Recognition of Molecular Subtypes
Q34898735Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors
Q57644499Is laparoscopic extirpation of the cervical stump after laparoscopic supracervical hysterectomy justified in women with incidentally found atypical endometrial hyperplasia?
Q47190168Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium
Q44303312Ki-67 as a prognostic molecular marker in routine clinical use in breast cancer patients
Q34074094Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Q35745601Knowledge and attitudes regarding medical research studies among patients with breast cancer and gynecological diseases
Q57191573Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair
Q37725393Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome
Q28267893Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair
Q29416989Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Q50984661Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation.
Q26800265Local and Systemic Therapies for Breast Cancer Patients: Reducing Short-term Symptoms with the Methods of Integrative Medicine
Q35686043Long-Term Endurance Exercise in Humans Stimulates Cell Fusion of Myoblasts along with Fusogenic Endogenous Retroviral Genes In Vivo
Q51749719Long-term administration of testosterone undecanoate every 3 months for testosterone supplementation in female-to-male transsexuals.
Q46671490Long-term disease-free survival after hormonal therapy of a patient with recurrent low grade endometrial stromal sarcoma: a case report
Q44827804Long-term effects of anastrozole on bone mineral density: 7-year results from the ATAC trial
Q38469677Loss of heterozygosity of BRCA1, TP53 and TCRD markers analysed in sporadic endometrial cancer
Q35119701Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium
Q46983578Low sex hormone-binding globulin as a predictive marker for insulin resistance in women with hyperandrogenic syndrome
Q38126358Low-dose methotrexate treatment in ectopic pregnancy: a retrospective analysis of 164 ectopic pregnancies treated between 2000 and 2008.
Q51057785Lymphedema in breast cancer survivors: assessment and information provision in a specialized breast unit.
Q38857155Major and minor complications after anterior rectal resection for deeply infiltrating endometriosis
Q45381957Major histocompatibility complex class II polymorphisms are associated with the development of anti-resorptive agent-induced osteonecrosis of the jaw.
Q36373761Malformations in a cohort of 284 women with Mayer-Rokitansky-Küster-Hauser syndrome (MRKH).
Q37382835Mammographic Density and Prediction of Nodal Status in Breast Cancer Patients
Q39622978Mammographic density is the main correlate of tumors detected on ultrasound but not on mammography
Q38528926Measuring bone density with ultrasound osteodensitometry--results of a pilot study
Q57561116Mechanisms of steroid hormone action and resistance in endometrial and breast cancer
Q37700515Meconium indicators of maternal alcohol abuse during pregnancy and association with patient characteristics
Q36333368Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.
Q34497352MicroRNA related polymorphisms and breast cancer risk
Q38076833Mild hydronephrosis after uncomplicated hysterectomy
Q61446881Mindfulness-based Stress Reduction in Pregnancy: an App-Based Programme to Improve the Health of Mothers and Children (MINDFUL/PMI Study)
Q34123806Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls
Q51585801Modulation of uterine contractility and peristalsis by oxytocin in estrogen-primed non-pregnant swine uteri.
Q36897003Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Q41540149Multistep carcinogenesis of breast cancer and tumour heterogeneity
Q39426753Mutation status of the mediator complex subunit 12 (MED12) in uterine leiomyomas and concurrent/metachronous multifocal peritoneal smooth muscle nodules (leiomyomatosis peritonealis disseminata).
Q39728677Myometrial response to neurotropic and musculotropic spasmolytic drugs in an extracorporeal perfusion model of swine uteri
Q46634705Neoadjuvant chemotherapy in breast cancer: which diagnostic procedures can be used?
Q46419524Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial
Q26799669Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk
Q36631808New Screening Proposals: the Federal Joint Commission Defines the Parameters for Cervical Cancer Screening from 2018: Statement of the Gynecology Oncology Working Group (AGO)
Q42062896New WHO Classification of Endometrial Hyperplasias
Q53254794New diagnostic criteria in real-time elastography for the assessment of breast lesions.
Q38845245Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates
Q30275832No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival
Q30374367No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Q26771342Non-embryo-destructive Extraction of Pluripotent Embryonic Stem Cells: Implications for Regenerative Medicine and Reproductive Medicine
Q35752042Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures
Q36027025Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium
Q36689214Oncofertility: combination of ovarian stimulation with subsequent ovarian tissue extraction on the day of oocyte retrieval
Q59616772Onkologie. Mammakarzinom: Bisphosphonate in der Adjuvanz – auch aus gesundheitsökonomischer Sicht eine sinnvolle Therapie
Q39205783Optimizing the quality of breast cancer care at certified german breast centers: a benchmarking analysis for 2003-2009 with a particular focus on the interdisciplinary specialty of radiation oncology
Q38927258Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor
Q47901041Ovarian tissue cryopreservation and retransplantation--what do patients think about it?
Q31108673Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis
Q39827385Oxytocin receptor DNA methylation in postpartum depression
Q47756678P(185/Her2) and ps2 protein overexpression in breast-cancer specimens - improvement for prediction of response to endocrine therapy.
Q28584533PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
Q47143943PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1.
Q36184231PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2.
Q52897474PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin-cyclophosphamide followed by paclitaxel with or without darbepoetin
Q33488582Pain perception and detailed visual pain mapping in breast cancer survivors
Q34289136Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche
Q37382870Participation in the SUCCESS-A Trial Improves Intensity and Quality of Care for Patients with Primary Breast Cancer
Q112572520Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes
Q52723445Pathway-Based Analysis of Genome-Wide Association Data Identified SNPs in HMMR as Biomarker for Chemotherapy- Induced Neutropenia in Breast Cancer Patients.
Q37307937Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium
Q51121776Patients' attitudes to totally implantable venous access port systems for gynecological or breast malignancies.
Q51029465Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant.
Q73157863Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis
Q34209634Percent Mammographic Density and Dense Area as Risk Factors for Breast Cancer
Q34209656Pilot Study on the Detection of Simulated Lesions Using a 2D and 3D Digital Full-Field Mammography System with a Newly Developed High Resolution Detector Based on Two Shifts of a-Se
Q45200398Placental defence is considered sufficient to control lipid peroxidation in pregnancy
Q62583133Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
Q42985583Polymorphism in HTR3D shows different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy
Q36066735Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression
Q46158039Polymorphisms in estrogen metabolism and estrogen pathway genes and the risk of miscarriage
Q36915870Polymorphisms in inflammation pathway genes and endometrial cancer risk
Q42013702Polymorphisms in the RANK/RANKL genes and their effect on bone specific prognosis in breast cancer patients
Q34767999Polymorphisms in the novel serotonin receptor subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy
Q41605982Porcine uterus cryopreservation: an analysis of contractile function using different uterotonics
Q36240019Precancerous Lesions of the Cervix, Vulva and Vagina According to the 2014 WHO Classification of Tumors of the Female Genital Tract
Q41011976Predicting Triple-Negative Breast Cancer Subtype Using Multiple Single Nucleotide Polymorphisms for Breast Cancer Risk and Several Variable Selection Methods
Q42481495Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype
Q36583004Prediction of breast cancer risk based on profiling with common genetic variants
Q58101133Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Q44634509Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers
Q41714412Pregnancies and live births after 20 transplantations of cryopreserved ovarian tissue in a single center
Q36010581Pregnancy and Obstetrical Outcomes in Women Over 40 Years of Age
Q34476150Pregnancy outcome after maternal intoxication with phenprocoumon
Q35269825Preliminary observations on whole-ovary xenotransplantation as an experimental model for fertility preservation
Q47755445Prenatal and adult androgen activities in alcohol dependence
Q57476250Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis
Q46635778Pretreatment with gonadotropin-releasing hormone (GnRH) antagonists to prevent the flare-up effect of long-acting GnRH agonists: results of a pilot study
Q34621091Prevalence of CA 27.29 in primary breast cancer patients before the start of systemic treatment.
Q46796735Prevalence of polycystic ovary syndrome and hyperandrogenemia in female-to-male transsexuals
Q34011730Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer
Q30316383Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015).
Q42512310Prognostic molecular markers and neoadjuvant therapy response in anthracycline-treated breast cancer patients
Q45756790Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis
Q45408422Prognostic significance of serum antibodies to HPV-16 L1 virus-like particles in patients with invasive cervical cancer
Q45393694Prognostic significance of the detection of human papilloma virus L1 protein in smears of mild to moderate cervical intraepithelial lesions
Q54574341Proliferation and cell-cell fusion of endometrial carcinoma are induced by the human endogenous retroviral Syncytin-1 and regulated by TGF-beta.
Q67779118Prolonged clearance of intraperitoneal 16α-[125I]iodo-17β-estradiol in presence of ascites
Q42488203Proteases associated with gynecological tumors.
Q73427342Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium
Q51090232Psychosomatic aspects of urinary incontinence.
Q55508030Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
Q43927056Quality assured health care in certified breast centers and improvement of the prognosis of breast cancer patients
Q43166541Quantification of fatty acid ethyl esters (FAEE) and ethyl glucuronide (EtG) in meconium from newborns for detection of alcohol abuse in a maternal health evaluation study
Q36009422RAD51B in Familial Breast Cancer
Q68040369Rapid liver metabolism, urinary and biliary excretion, and enterohepatic circulation of 16 alpha-radioiodo-17 beta-estradiol
Q68073872Rat ovarian apolipoprotein E: localization and gonadotropic control of messenger RNA
Q48173831Re-irradiation of the chest wall for local breast cancer recurrence : Results of salvage brachytherapy with hyperthermia
Q30418097Reactivation of codogenic endogenous retroviral (ERV) envelope genes in human endometrial carcinoma and prestages: Emergence of new molecular targets
Q44093156Recurrent aberrations identified by array-CGH in patients with Mayer-Rokitansky-Küster-Hauser syndrome
Q34606561Reduced syncytin-1 expression levels in placental syndromes correlates with epigenetic hypermethylation of the ERVW-1 promoter region
Q35155449Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia
Q40974954Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in squamous-cell carcinoma by interferon-gamma and cisplatin
Q39133966Regulation of murine placentogenesis by the retroviral genes Syncytin-A, Syncytin-B and Peg10.
Q39351091Regulation of the human endogenous retroviral Syncytin-1 and cell-cell fusion by the nuclear hormone receptors PPARγ/RXRα in placentogenesis
Q26830250Relevance of health economics in breast cancer treatment - the view of certified breast centres and their patients
Q47119993Repetitive Maturation of Oocytes From Non-Stimulated Xenografted Ovarian Tissue From a Prepubertal Patient Indicating the Independence of Human Ovarian Tissue
Q36799061Replication of Epigenetic Postpartum Depression Biomarkers and Variation with Hormone Levels
Q62583612Reply of the Authors: Comparing high-sensitivity C-reactive protein (hs-CRP) with CRP as a soluble serum marker for the diagnosis of women with endometriosis
Q45951126Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study.
Q73721789Resistance to CD95-mediated apoptosis in breast cancer is not due to somatic mutation of the CD95 gene
Q42970092Results of the Zometa cost-utility model for the german healthcare system based on the results of the ABCSG-12 study
Q35694239Retransplantation of cryopreserved ovarian tissue: the first live birth in Germany
Q37444964Review. Fertility preservation for young female cancer patients.
Q34201814Risk Factors for Endometriosis in a German Case-Control Study
Q36771007Risk and risk assessment for breast cancer: molecular and clinical aspects
Q37300024Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.
Q37624504Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10
Q54950358Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data.
Q43902013Role of estrogen receptor isoforms in the pathogenesis and treatment of endometrial cancer
Q46681913Role of insulin in the progression of ovarian sex cord stromal tumors in rats
Q53584046SPECT/Spiral-CT hybrid imaging in unclear foci of increased bone metabolism: a case report.
Q46148436Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial
Q55013059Saliva samples as a source of DNA for high throughput genotyping: an acceptable and sufficient means in improvement of risk estimation throughout mammographic diagnostics.
Q36295510Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015).
Q35121889Selective expression of sense and antisense transcripts of the sushi-ichi-related retrotransposon--derived family during mouse placentogenesis
Q36678970Selective isolation and characterization of primary cells from normal breast and tumors reveal plasticity of adipose derived stem cells
Q64328965Self-reported Improvement in Side Effects and Quality of Life With Integrative Medicine in Breast Cancer Patients
Q39102961Semi-automated delineation of breast cancer tumors and subsequent materialization using three-dimensional printing (rapid prototyping).
Q37382822Shaping the System - The DRG Evaluation Project of the German Society for Gynaecology and Obstetrics (Deutsche Gesellschaft für Gynäkologie und Geburtshilfe, DGGG).
Q42599064Shared decision-making in metastatic breast cancer: discrepancy between the expected prolongation of life and treatment efficacy between patients and physicians, and influencing factors
Q36089391Shared genetics underlying epidemiological association between endometriosis and ovarian cancer
Q61118451Shared heritability and functional enrichment across six solid cancers
Q64004349Shared heritability and functional enrichment across six solid cancers
Q47137402Shifting cancer care towards Multidisciplinarity: the cancer center certification program of the German cancer society
Q41514112Should Breast Cancer Surgery Be Done in an Outpatient Setting?: Health Economics From the Perspective of Service Providers
Q50647639Simple prediction of the survival of follicles in cryopreserved human ovarian tissue.
Q64882721Simultaneously reduced gene expression of cortisol-activating and cortisol-inactivating enzymes in placentas of small-for-gestational-age neonates.
Q40816253Single deepest vertical pocket or amniotic fluid index as evaluation test for predicting adverse pregnancy outcome (SAFE trial): a multicenter, open-label, randomized controlled trial
Q54547212Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer.
Q44470032Single nucleotide polymorphisms in the progesterone receptor gene and association with uterine leiomyoma tumor characteristics and disease risk
Q30597718Single-source tumor documentation - reusing oncology data for different purposes
Q46037164Smoking is associated with increased free testosterone and fasting insulin levels in women with polycystic ovary syndrome, resulting in aggravated insulin resistance.
Q44192343Socioeconomic status and depression during and after pregnancy in the Franconian Maternal Health Evaluation Studies (FRAMES).
Q44499781Sonographic weight estimation in fetuses with breech presentation
Q33678242Spontaneous antral follicle formation and metaphase II oocyte from a non-stimulated prepubertal ovarian tissue xenotransplant
Q64273100Standards Used by a Clinical and Scientific Endometriosis Center for the Diagnosis and Therapy of Patients with Endometriosis
Q38950938State-of-the-Art Treatment and Novel Agents in Local and Distant Recurrences of Cervical Cancer
Q53094486Subjective assessment of ovarian masses using pattern recognition: the impact of experience on diagnostic performance and interobserver variability.
Q59335365Supportive Infusions in Integrative Breast and Gynecological Oncology – Report on Patientsʼ Satisfaction and Self-reported Effects and Side Effects
Q35180929Surgical Methods for the Treatment of Uterine Fibroids - Risk of Uterine Sarcoma and Problems of Morcellation: Position Paper of the DGGG
Q62583463TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes
Q48769304The 5-HTTLPR polymorphism modulates the influence on environmental stressors on peripartum depression symptoms.
Q49817640The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity.
Q46447105The G20210A prothrombin-gene mutation and the plasminogen activator inhibitor (PAI-1) 5G/5G genotype are associated with early onset of severe preeclampsia
Q34791139The German SUCCESS C Study - The First European Lifestyle Study on Breast Cancer
Q33769034The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial
Q51341861The Hohl instrument for optimizing total laparoscopic hysterectomy procedures.
Q43957623The Hohl instrument for optimizing total laparoscopic hysterectomy: results of more than 500 procedures in a university training center
Q37210385The International Endometriosis Evaluation Program (IEEP Study) - A Systematic Study for Physicians, Researchers and Patients
Q39147158The PI3K Pathway: Background and Treatment Approaches
Q36917100The UGT1A6_19_GG genotype is a breast cancer risk factor
Q51833268The VCUAM (Vagina Cervix Uterus Adnex-associated Malformation) classification: a new classification for genital malformations.
Q43537095The association of prenatal attachment and perinatal factors with pre- and postpartum depression in first-time mothers
Q38162087The concept of the certification system of the German Cancer Society and its impact on gynecological cancer care
Q36137764The contributions of breast density and common genetic variation to breast cancer risk
Q43226777The effect of metformin treatment for 2 years without caloric restriction on endocrine and metabolic parameters in women with polycystic ovary syndrome
Q51781776The era of centers: the influence of establishing specialized centers on patients' choice of hospital.
Q51745778The extracorporeal perfusion of the female pig detrusor as an experimental model for the study of bladder contractility.
Q28192341The extracorporeal perfusion of the swine uterus as an experimental model: The effect of tocolytic drugs
Q43069798The impact of testosterone administration to female-to-male transsexuals on insulin resistance and lipid parameters compared with women with polycystic ovary syndrome
Q43701922The influence of hormones on CD44 expression in endometrial and breast carcinomas.
Q28389045The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial
Q36357800The integrative epigenomic-transcriptomic landscape of ER positive breast cancer
Q43186750The intrauterine to intra-arterial pressure ratio: a new parameter for the study of uterine contractility physiology
Q36608476The perfused swine uterus model: long-term perfusion
Q40923573The placental mTOR-pathway: correlation with early growth trajectories following intrauterine growth restriction?
Q57265642The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant
Q35024008The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing
Q36142060The role of genetic breast cancer susceptibility variants as prognostic factors
Q21195217The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer
Q61814603Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry
Q37884968Thyroid hormone receptors and reproduction
Q43298736Thyroid-stimulating hormone is associated with insulin resistance independently of body mass index and age in women with polycystic ovary syndrome
Q36393138Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE trial bone substudy
Q34129643Time and Resources Needed to Document Patients with Breast Cancer from Primary Diagnosis to Follow-up - Results of a Single-center Study
Q39376175Timing of sequential use of double-balloon catheter and oral misoprostol for induction of labor
Q52887281Tissue remodeling and nonendometrium-like menstrual cycling are hallmarks of peritoneal endometriosis lesions.
Q36998911Topotecan in cervical cancer
Q36539580Touch Imprint Cytology and Stereotactically-Guided Core Needle Biopsy of Suspicious Breast Lesions: 15-Year Follow-up
Q28547437Towards a Computable Data Corpus of Temporal Correlations between Drug Administration and Lab Value Changes
Q33432594Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial
Q55044220Transcriptional analysis of steroid hormone receptors in smooth muscle uterine leiomyoma tumors of postmenopausal patients.
Q47663023Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry
Q44267362Treatment of endometrial carcinoma - evidence based criteria
Q37814633Treatment of heterotopic cervical pregnancies
Q38864593Trophoblast expression dynamics of the tumor suppressor gene gastrokine 2.
Q37441942Twenty-five-year-old Woman with Bilateral Borderline Ovarian Tumour Desiring to Preserve Fertility - Case Report and Literature Review on the Current State of Fertility Preservation in Women with Borderline Ovarian Tumours
Q43215450Two naturally occurring variants of the serotonin receptor gene HTR3C are associated with nausea in pregnancy
Q47110841Update Breast Cancer 2017 - Implementation of Novel Therapies
Q52632717Update Breast Cancer 2018 (Part 1) - Primary Breast Cancer and Biomarkers.
Q52632715Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention.
Q36995438Update on ovarian hyperstimulation syndrome: Part 1--Incidence and pathogenesis.
Q37102399Update on ovarian hyperstimulation syndrome: part 2--clinical signs and treatment.
Q39046820Updates on the role of receptor activator of nuclear factor κB/receptor activator of nuclear factor κB ligand/osteoprotegerin pathway in breast cancer risk and treatment
Q34201823Use of Tomosynthesis in Intraoperative Digital Specimen Radiography - Is a Reduction of Breast Re-excision Rates Possible?
Q56968394Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among Physicians
Q41570633Using automated texture features to determine the probability for masking of a tumor on mammography, but not ultrasound
Q60046304Uterine contractility changes in a perfused swine uterus model induced by local anesthetics procaine, lidocaine, and ropivacaine
Q51586397Uterine contractility in response to different prostaglandins: results from extracorporeally perfused non-pregnant swine uteri.
Q37800777Uterus cryopreservation in the sheep: one step closer to uterus transplantation.
Q46258165Uterus cryopreservation: maintenance of uterine contractility by the use of different cryoprotocols
Q37365192Utilisation of prophylactic mastectomy in 10 European centres
Q56342454Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility
Q33847791Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer
Q38424468Xenotransplantation of cryopreserved human ovarian tissue--a systematic review of MII oocyte maturation and discussion of it as a realistic option for restoring fertility after cancer treatment
Q51997885Xenotransplantation of human ovarian tissue pieces in gonadotropin-stimulated SCID mice: the effect of ovariectomy.
Q34096155Zurich Consensus: German Expert Opinion on the St. Gallen Votes on 15 March 2009 (11th International Conference at St. Gallen: Primary Therapy of Early Breast Cancer).
Q72990970[Chronic pelvic pain and chronic vulvodynia as multifactorial psychosomatic disease syndromes: results of a psychometric and clinical study taking into account musculoskeletal diseases]
Q53050911[Documentation Time and Effort and Associated Resources for Patients with Primary Breast Cancer from Diagnosis to End of Follow-Up - Results of a Multicentre Validation].
Q53077783[Future of mammography-based imaging].
Q53411285[Hereditary cancer syndromes in gynecology: what the practitioner needs to know!]
Q73792047[Inflammation of the myocardium as an arrhythmia trigger]
Q50449749[Pre-, peri- and postpartal depression].
Q70841560[Prenatal determination of fetal rhesus factor in amnionic cells using polymerase chain reaction]
Q54510092[Reconstructive surgery of the efferent urinary tract in pelvic exenteration of gynecological tumors]
Q67551417[Regulation of sterol carrier protein-2 in human luteal cells by LH and LH-RH]
Q53311354[S3 guidelines on diagnostics and treatment of cervical cancer: Demands on pathology].
Q54384993[Sebaceous breast carcinoma: report of a rare histological special subtype].
Q58587476[TILGen study-immunological targets in patients with breast cancer : Influence of tumor-infiltrating lymphocytes]
Q72665378[The erbB gene family: significance for tumor development, prognosis and new therapeutic modalities]
Q74602870[Tumor risk consultation for predisposed women from high risk cancer families]
Q73786002int-2 and c-erbB-2 gene amplification detected in 70 frozen human breast carcinomas by quantitative polymerase chain reaction
Q122925830p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
Q38477520pS2 protein detected by immunohistochemistry in archival primary breast cancer.
Q37414133rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk
Q56334023rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology

Search more.